Abstract
DNA-binding activity of the wild-type p53 is central to its function in vivo. However, recombinant or in vitro translated wild-type p53 proteins, unless modified, are poor DNA binders. The fact that the in vitro produced protein gains DNA-binding activity upon modification at the C terminus raises the possibility that similar mechanisms may exist in the cell. Data presented here show that a C-terminal alternatively spliced wild-type p53 (ASp53) mRNA expressed by bacteria or transcribed in vitro codes for a p53 protein that efficiently binds DNA. Our results support the conclusion that the augmented DNA binding activity of an ASp53 protein is probably due to attenuation of the negative effect residing at the C terminus of the wild-type p53 protein encoded by the regularly spliced mRNA (RSp53) rather than acquisition of additional functionality by the alternatively spliced C' terminus. In addition, we found that ASp53 forms a complex with the non-DNA-binding RSp53, which in turn blocks the DNA-binding activity of ASp53. Interaction between these two wild-type p53 proteins may underline a mechanism that controls the activity of the wild-type p53 protein in the cell.
MeSH Terms
Alternative Splicing
Amino Acid Sequence
Animals
Base Sequence
Binding, Competitive
DNA/metabolism
Mice
Molecular Sequence Data
Protein Binding
Protein Biosynthesis
RNA, Messenger/metabolism
Recombinant Proteins/metabolism
Sequence Deletion
Structure-Activity Relationship
Tumor Suppressor Protein p53/genetics,metabolism
Chemicals
RNA, Messenger
Recombinant Proteins
Tumor Suppressor Protein p53
DNA
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wolkowicz R
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Peled A
Elkind N B
Rotter V
References (30)
30 references, click to expand
-
Wild-type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells.
EMBO J. 1994 Oct 17;13(20):4823-30
PMID: 7957051
-
How loops, beta sheets, and alpha helices help us to understand p53.
Cell. 1994 Aug 26;78(4):543-6
PMID: 8069906
-
Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.
Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1958-62
PMID: 1705714
-
p53 mutations in human cancers.
Science. 1991 Jul 5;253(5015):49-53
PMID: 1905840
-
A DNA binding domain is contained in the C-terminus of wild type p53 protein.
Nucleic Acids Res. 1991 Oct 11;19(19):5191-8
PMID: 1923804
-
Alternatively spliced p53 RNA in transformed and normal cells of different tissue types.
Nucleic Acids Res. 1992 Apr 25;20(8):1979-81
PMID: 1579500
-
A transcriptionally active DNA-binding site for human p53 protein complexes.
Mol Cell Biol. 1992 Jun;12(6):2866-71
PMID: 1588974
-
Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.
Nucleic Acids Res. 1992 Jul 11;20(13):3435-41
PMID: 1630914
-
Regulation of the specific DNA binding function of p53.
Cell. 1992 Nov 27;71(5):875-86
PMID: 1423635
-
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
EMBO J. 1993 Mar;12(3):1029-37
PMID: 8458321
-
Definition of a consensus binding site for p53.
Nat Genet. 1992 Apr;1(1):45-9
PMID: 1301998
-
Activation of the cryptic DNA binding function of mutant forms of p53.
Nucleic Acids Res. 1993 Jul 11;21(14):3167-74
PMID: 8341590
-
p53: at the crossroads of molecular carcinogenesis and risk assessment.
Science. 1993 Dec 24;262(5142):1980-1
PMID: 8266092
-
The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
Genes Dev. 1993 Dec;7(12B):2556-64
PMID: 8276238
-
A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Genes Dev. 1993 Dec;7(12B):2565-74
PMID: 8276239
-
Monoclonal antibodies specific for simian virus 40 tumor antigens.
J Virol. 1981 Sep;39(3):861-9
PMID: 6169844
-
Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.
Mol Cell Biol. 1985 Jan;5(1):127-32
PMID: 2580227
-
Monoclonal antibody analysis of p53 expression in normal and transformed cells.
J Virol. 1986 Aug;59(2):444-52
PMID: 2426467
-
Immunologically distinct p53 molecules generated by alternative splicing.
Mol Cell Biol. 1986 Sep;6(9):3232-9
PMID: 3023970
-
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
EMBO J. 1990 May;9(5):1595-602
PMID: 1691710
-
Presence of a potent transcription activating sequence in the p53 protein.
Science. 1990 Aug 31;249(4972):1046-9
PMID: 2144363
-
Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
Science. 1990 Aug 31;249(4972):1049-51
PMID: 2144364
-
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.
Mol Cell Biol. 1991 Jan;11(1):12-9
PMID: 1986215
-
A potential transcriptional activation element in the p53 protein.
Oncogene. 1990 Dec;5(12):1829-32
PMID: 2284102
-
p53 domains: identification and characterization of two autonomous DNA-binding regions.
Genes Dev. 1993 Dec;7(12B):2575-86
PMID: 8276240
-
Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.
Mol Cell Biol. 1994 Mar;14(3):1698-708
PMID: 8114705
-
p53: a glimpse at the puppet behind the shadow play.
Science. 1994 Jul 15;265(5170):334-5
PMID: 8023155
-
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
Science. 1994 Jul 15;265(5170):346-55
PMID: 8023157
-
High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
Science. 1994 Jul 15;265(5170):386-91
PMID: 8023159
-
The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
Oncogene. 1995 Mar 16;10(6):1167-74
PMID: 7535417